You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search


( LETT-row-zole )
ODB Limited Use
  • letrozole - Treatment of metastatic breast cancer in hormone receptor positive postmenopausal women
  • letrozole - As an alternative to tamoxifen for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer for a maximum of five years
  • letrozole - Treatment of hormone receptor positive early breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy
Other Name(s): Femara® (multiple brands available)
Appearance: tablet

You might also be interested in